Literature DB >> 27687957

Toll-like receptors and autophagy in interstitial lung diseases.

George A Margaritopoulos1, Ismini Lasithiotaki2, Katerina M Antoniou2.   

Abstract

Interstitial lung diseases (ILDs) include a number of diseases whose pathogenesis still is not fully understood. Idiopathic pulmonary fibrosis (IPF), the most frequent and severe form of ILDs is an epithelial-driven disease and the treatment consists of the use of antifibrotic agents. In the rest of ILDs an inflammation-driven pathway is believed to be the main pathogenetic mechanism and treatment consists of the use of immunomodulatory agents. In both groups it is believed that infection can play an important role in the development and progression of the diseases. The immune system can recognize exogenous threats or endogenous stress through specialized receptors namely pattern recognition receptors (PRRs) which in turn, initiate downstream signaling pathways to control immune responses. Recently, a link between PRRs and autophagy, a specialized biological process involved in maintaining cellular homeostasis but also involved in various immunologic processes, has been described. In this review, we focus on the reciprocal influences of PRRs with particular emphasis on Toll-like receptors and autophagy in modulating innate immune responses.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; Idiopathic pulmonary fibrosis; Infection; Inflammation; Innate immunity; Toll-like receptors

Mesh:

Substances:

Year:  2016        PMID: 27687957     DOI: 10.1016/j.ejphar.2016.09.032

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Normal lung development needs self-eating.

Authors:  David Warburton; Saverio Bellusci
Journal:  J Clin Invest       Date:  2019-06-04       Impact factor: 14.808

Review 2.  Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis.

Authors:  Hongbo Ma; Xuyi Wu; Yi Li; Yong Xia
Journal:  Front Pharmacol       Date:  2022-07-21       Impact factor: 5.988

Review 3.  The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis.

Authors:  Lucy A Murtha; Michael J Schuliga; Nishani S Mabotuwana; Sean A Hardy; David W Waters; Janette K Burgess; Darryl A Knight; Andrew J Boyle
Journal:  Front Physiol       Date:  2017-10-12       Impact factor: 4.566

4.  Effects of New NSAID-CAI Hybrid Compounds in Inflammation and Lung Fibrosis.

Authors:  Laura Lucarini; Mariaconcetta Durante; Silvia Sgambellone; Cecilia Lanzi; Elisabetta Bigagli; Ozlem Akgul; Emanuela Masini; Claudiu T Supuran; Fabrizio Carta
Journal:  Biomolecules       Date:  2020-09-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.